HOSE:VDP Revenue

In the year 2025, Vidipha Central Pharmaceutical JSC had annual revenue of 950.89B VND with 1.76% growth. Vidipha Central Pharmaceutical JSC had revenue of 156.84B in the quarter ending December 31, 2025, a decrease of -46.67%.

Revenue

950.89B

Revenue Growth

+1.76%

P/S Ratio

1.16

Revenue / Employee

4.88B

Employees

195

Market Cap

1,104.17B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	950.89B	16.41B	1.76%
Dec 31, 2024	934.49B	-84.83B	-8.32%
Dec 31, 2023	1,019.32B	11.52B	1.14%
Jan 1, 2023	1,007.80B	800.84B	386.97%
Dec 31, 2008	206.95B	15.51B	8.10%
Dec 31, 2007	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Pharmedic Pharmaceutical Medicinal JSC	546.57B
Central Pharmaceutical Joint Stock Company No3	438.01B
OPC Pharmaceutical JSC	1,122.99B
Domesco Medical Import - Export Joint-Stock	2,078.82B
Traphaco JSC	2,651.81B
Cuu Long Pharmaceutical JSC	1,321.59B
Mediplantex National Pharmaceutical JSC	367.08B
Vimedimex Medi-Pharma JSC	1,172.99B

Revenue Rankings